Matches in Nanopublications for { ?s ?p "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP48596.RA0n-mHOcuO60fmO6qq9roXxL4eyZE2HP_o3E_GdozMps130_assertion description "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP48596.RA0n-mHOcuO60fmO6qq9roXxL4eyZE2HP_o3E_GdozMps130_provenance.
- assertion description "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP461087.RA7YDyFUvK2vU-Gr8CXOPga7DpA04kvOafXo6GYaD_sQw130_assertion description "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP461087.RA7YDyFUvK2vU-Gr8CXOPga7DpA04kvOafXo6GYaD_sQw130_provenance.
- NP740075.RAPLNIsLTDtfBYOtAaJiHsS16Tix-mWWiZY6IvM0TkZgY130_assertion description "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP740075.RAPLNIsLTDtfBYOtAaJiHsS16Tix-mWWiZY6IvM0TkZgY130_provenance.
- NP743410.RAXTKG9y4hUNzJEzWHASQ9o9WpluC_G5xqnhlBRqpCrRs130_assertion description "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743410.RAXTKG9y4hUNzJEzWHASQ9o9WpluC_G5xqnhlBRqpCrRs130_provenance.
- NP236891.RABtvQ6F89sQ5a5Wor5d_-ZDCHyvbfksJbitydk1LBa0I130_assertion description "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236891.RABtvQ6F89sQ5a5Wor5d_-ZDCHyvbfksJbitydk1LBa0I130_provenance.
- NP743409.RA21BI9T7zPZfUIUqk708A5efF66iKAwlY1v3DpOUYLjw130_assertion description "[Mild hypophosphatasia (HPP) phenotype may result from ALPL gene mutations exhibiting residual alkaline phosphatase activity or from severe heterozygous mutations exhibiting a dominant negative effect.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP743409.RA21BI9T7zPZfUIUqk708A5efF66iKAwlY1v3DpOUYLjw130_provenance.